speb/financial-data huggingface dataset:
Financial ratios for DHY — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.61
Shares outstanding: 138146165
Market cap (USD): 222415325.65
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHY — annual report dated 2022-10-31
Total revenue: -37167802
Net income: -37424902
Capital expenditures: 0
Operating cash flow: 9258895
Net tangible assets: 206835460
Owner earnings: -37424902
Return on net tangible assets (%): -18.094045382740465
Buffett classification: The Gruesome
Stock price: 1.26
Shares outstanding: 138146165
Book value: 206835460
P/B ratio: 0.8415586374792795
Market cap (USD): 174064167.9
Debt to equity: 0.44238062467625233
Free cash flow (dilution-adjusted): 9258895
Buyback yield (%): 0
Retained earnings: -86488145
Receivables turnover: -6.190874773866468
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHY — annual report dated 2023-10-31
Total revenue: 22782729
Net income: 22585593
Capital expenditures: 0
Operating cash flow: 31404055
Net tangible assets: 210167498
Owner earnings: 22585593
Return on net tangible assets (%): 10.746472796664307
Buffett classification: The Gruesome
Stock price: 1.42
P/E ratio: 8.685517103757249
Shares outstanding: 138146165
Book value: 210167498
P/B ratio: 0.9333867328048983
Market cap (USD): 196167554.29999998
Debt to equity: 0.38064877186671364
COGS to revenue (%): 0
SG&A to revenue (%): 2.6215911184301053
Free cash flow (dilution-adjusted): 31404055
Buyback yield (%): 0
Retained earnings: -81560270
Receivables turnover: 4.332010751530948
Capitalized R&D asset: 0
FCF margin (%): 137.84149826827155
Rule of 40 score: 137.84149826827155
Financial ratios for DHY — annual report dated 2024-10-31
Total revenue: 37802916
Net income: 37464675
Capital expenditures: 0
Operating cash flow: 18132898
Net tangible assets: 228453894
Owner earnings: 37464675
Return on net tangible assets (%): 16.399228021037803
Buffett classification: The Gruesome
Stock price: 1.84
P/E ratio: 6.7847630761510676
Shares outstanding: 138146165
Book value: 228453894
P/B ratio: 1.1126487675451924
Market cap (USD): 254188943.60000002
Debt to equity: 0.3501800674056359
COGS to revenue (%): 0
SG&A to revenue (%): 1.9450324943186923
Free cash flow (dilution-adjusted): 18132898
Buyback yield (%): 0
Retained earnings: -62215847
Receivables turnover: 6.12793558966618
Capitalized R&D asset: 0
FCF margin (%): 47.96692932365323
Revenue growth (%): 65.92795358273365
Rule of 40 score: 113.89488290638688
Financial ratios for DHY — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 228453894
Buffett classification: The Gruesome
Stock price: 1.84
Shares outstanding: 138146165
Book value: 228453894
P/B ratio: 1.1126487675451924
Market cap (USD): 254188943.60000002
Debt to equity: 0.3501800674056359
Buyback yield (%): 0
Retained earnings: -62215847
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHY — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 221138163
Buffett classification: The Gruesome
Stock price: 1.81
Shares outstanding: 138146165
Market cap (USD): 250044558.65
Buyback yield (%): 0
Retained earnings: -69666980
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHY — quarterly report dated 2025-10-31
Capital expenditures: 0
Net tangible assets: 221671691
Buffett classification: The Gruesome
Stock price: 1.95
Shares outstanding: 138146165
Book value: 221671691
P/B ratio: 1.2152432299079634
Market cap (USD): 269385021.75
Debt to equity: 0.4285617147207128
Buyback yield (%): 0
Retained earnings: -68013940
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DHY — annual report dated 2025-10-31
Total revenue: 12897255
Net income: 12351115
Capital expenditures: 0
Operating cash flow: 5152633
Net tangible assets: 221671691
Owner earnings: 12351115
Return on net tangible assets (%): 5.57180528748707
Buffett classification: The Gruesome
Stock price: 1.95
P/E ratio: 21.810583234792972
Shares outstanding: 138146165
Book value: 221671691
P/B ratio: 1.2152432299079634
Market cap (USD): 269385021.75
Debt to equity: 0.4285617147207128
COGS to revenue (%): 0
SG&A to revenue (%): 7.276075412946398
Free cash flow (dilution-adjusted): 5152633
Buyback yield (%): 0
Retained earnings: -68013940
Receivables turnover: 1.647994155914517
Capitalized R&D asset: 0
FCF margin (%): 39.95139275760617
Revenue growth (%): -65.88290966760341
Rule of 40 score: -25.931516909997242
Financial ratios for EGL.LS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.1818181818181819
Shares outstanding: 306775950
Market cap (USD): 362553395.4545455
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EGL.LS — annual report dated 2022-12-31
Total revenue: 4047081914.893617
Gross profit: 3062864893.6170216
Operating income: 218344680.85106385
Net income: 105752127.65957448
Capital expenditures: 252728723.40425533
Depreciation & amortization: 296442553.1914894
Net tangible assets: -572722340.425532
Owner earnings: 149465957.44680852
Return on net tangible assets (%): -26.097455415438397
Capex to operating income (%): 115.74759798093976
Buffett classification: The Gruesome
Stock price: 1.0638297872340425
P/E ratio: 3.086059834820485
Shares outstanding: 306775950
Book value: 588947872.3404255
P/B ratio: 0.5541362978698039
Market cap (USD): 326357393.61702126
Debt to equity: 4.221516552236137
Current ratio: 0.9603898603198775
Quick ratio: 0.862243816499762
Effective tax rate (%): 28.516057585825028
Interest coverage ratio: 1.1154443973435073
COGS to revenue (%): 24.319177174412772
SG&A to revenue (%): 4.933157775618209
Free cash flow (dilution-adjusted): 647730851.0638298
Buyback yield (%): 0
Retained earnings: 55768085.10638298
Inventory turnover: 2.4698109127603853
Receivables turnover: 4.13201683976374
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.8813353004287725
FCF margin (%): 16.0048861052237
Rule of 40 score: 16.0048861052237
Financial ratios for EGL.LS — annual report dated 2023-12-31
Total revenue: 6168773333.333333
Gross profit: 4463610000
Operating income: 464250000
Net income: 295421111.1111111
Capital expenditures: 471835555.5555555
Depreciation & amortization: 312611111.1111111
Net tangible assets: -423352222.2222222
Owner earnings: 136196666.6666667
Return on net tangible assets (%): -32.17100549319322
Capex to operating income (%): 101.63393765332376
Buffett classification: The Gruesome
Stock price: 3.9666666666666663
P/E ratio: 4.11912991059843
Shares outstanding: 306775950
Book value: 828343333.333334
P/B ratio: 1.4690501945650545
Market cap (USD): 1216877935
Debt to equity: 3.2051390392335946
Current ratio: 1.0030673982195086
Quick ratio: 0.8893014666638203
Effective tax rate (%): 32.812349959315284
Interest coverage ratio: 1.4728587895644083
COGS to revenue (%): 27.641854242226437
SG&A to revenue (%): 1.6739686766466806
Free cash flow (dilution-adjusted): -142893333.33333334
Buyback yield (%): 0
Retained earnings: 125725555.55555555
Inventory turnover: 2.8798516019223444
Receivables turnover: 3.3851207983961835
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.601791250912118
FCF margin (%): -2.3163978575967565
Revenue growth (%): 52.425215576480056
Rule of 40 score: 50.1088177188833
Financial ratios for EGL.LS — annual report dated 2024-12-31
Total revenue: 6198868750
Gross profit: 4601102083.333334
Operating income: 543756250
Net income: 284666666.6666667
Capital expenditures: 400819791.6666667
Depreciation & amortization: 295966666.6666667
Net tangible assets: -360169791.6666667
Owner earnings: 179813541.6666667
Return on net tangible assets (%): -49.92465937650935
Capex to operating income (%): 73.71313739688816
Buffett classification: The Good
Stock price: 2.8229166666666665
P/E ratio: 3.042164902298009
Shares outstanding: 306775950
Book value: 883996875
P/B ratio: 0.9796448004270377
Market cap (USD): 866002942.1875
Debt to equity: 3.313086749693921
Current ratio: 0.9324652305839809
Quick ratio: 0.8443580565934136
Effective tax rate (%): 33.531803942171116
Interest coverage ratio: 1.6412341184127373
COGS to revenue (%): 25.775133029984975
SG&A to revenue (%): 1.3698736026096159
Free cash flow (dilution-adjusted): -16820833.333333336
Buyback yield (%): 0
Retained earnings: 127800000
Inventory turnover: 3.764830628078848
Receivables turnover: 3.9672548413075126
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.2764774241305
FCF margin (%): -0.27135327447178703
Revenue growth (%): 0.48786711782786074
Rule of 40 score: 0.2165138433560737
Financial ratios for EGL.LS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -360169791.6666667
Buffett classification: The Gruesome
Stock price: 2.8229166666666665
Shares outstanding: 306775950
Book value: 883996875
P/B ratio: 0.9796448004270377
Market cap (USD): 866002942.1875
Debt to equity: 3.313086749693921
Current ratio: 0.9324652305839809
Quick ratio: 0.8443580565934136
Buyback yield (%): 0
Retained earnings: 127800000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EGL.LS — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -622650588.2352941
Buffett classification: The Gruesome
Stock price: 4.352941176470589
Shares outstanding: 306775950
Book value: 913387058.8235283
P/B ratio: 1.4620063332470372
Market cap (USD): 1335377664.7058825
Debt to equity: 3.5660959402559875
Buyback yield (%): 0
Retained earnings: 69923529.41176471
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR.DE — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 90.59302325581395
Shares outstanding: 560100000
Market cap (USD): 50741152325.58139
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR.DE — annual report dated 2022-09-30
Total revenue: 13804000000
Gross profit: 6306000000
Operating income: 2356000000
Net income: 3231000000
Capital expenditures: 299000000
Operating cash flow: 2922000000
Depreciation & amortization: 842000000
Net tangible assets: -10154000000
Owner earnings: 3774000000
Return on net tangible assets (%): -37.167618672444355
Capex to operating income (%): 12.69100169779287
Buffett classification: The Great
Stock price: 72.23529411764706
P/E ratio: 12.522125730515047
Shares outstanding: 560100000
Book value: 16316000000
P/B ratio: 2.4797124439381046
Market cap (USD): 40458988235.29412
Debt to equity: 0.654939936258887
Current ratio: 1.0937379452230938
Quick ratio: 0.8697441172688698
Effective tax rate (%): 22.574013157894736
Interest coverage ratio: 10.333333333333334
COGS to revenue (%): 54.31758910460736
SG&A to revenue (%): 26.18081715444799
Free cash flow (dilution-adjusted): 2498000000
Buyback yield (%): 1.2358193365889174
Retained earnings: 28053000000
Inventory turnover: 4.304247990815155
Receivables turnover: 6.105263157894737
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.445958056999462
FCF margin (%): 18.096203998840917
Rule of 40 score: 18.096203998840917
Financial ratios for EMR.DE — annual report dated 2023-09-30
Total revenue: 15165000000
Gross profit: 7427000000
Operating income: 2759000000
Net income: 13219000000
Capital expenditures: 363000000
Operating cash flow: 637000000
Depreciation & amortization: 1051000000
Net tangible assets: -54000000
Owner earnings: 13907000000
Return on net tangible assets (%): -25753.7037037037
Capex to operating income (%): 13.156940920623414
Buffett classification: The Great
Stock price: 95.1263157894737
P/E ratio: 4.030580942104866
Shares outstanding: 560100000
Book value: 26598000000
P/B ratio: 2.0031675116055423
Market cap (USD): 53280249473.68422
Debt to equity: 0.3218663057372735
Current ratio: 2.7462241653418125
Quick ratio: 2.3475755166931638
Effective tax rate (%): 22.11505339304168
Interest coverage ratio: 10.57088122605364
COGS to revenue (%): 51.025387405209365
SG&A to revenue (%): 27.60303330036268
Free cash flow (dilution-adjusted): 24000000
Buyback yield (%): 4.155385948584048
Retained earnings: 40070000000
Inventory turnover: 3.8574277168494517
Receivables turnover: 6.02263701350278
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.315585724134274
FCF margin (%): 0.1582591493570722
Revenue growth (%): 9.859461025789626
Rule of 40 score: 10.017720175146698
Financial ratios for EMR.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 88.58888888888889
Shares outstanding: 560100000
Market cap (USD): 49618636666.666664
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR.DE — annual report dated 2024-09-30
Total revenue: 17492000000
Gross profit: 8885000000
Operating income: 2666000000
Net income: 1968000000
Capital expenditures: 419000000
Operating cash flow: 3332000000
Depreciation & amortization: 1689000000
Net tangible assets: -6867000000
Owner earnings: 3238000000
Return on net tangible assets (%): -47.1530508227756
Capex to operating income (%): 15.71642910727682
Buffett classification: The Great
Stock price: 88.58888888888889
P/E ratio: 25.212721883468834
Shares outstanding: 560100000
Book value: 27509000000
P/B ratio: 1.8037237510148194
Market cap (USD): 49618636666.666664
Debt to equity: 0.3037551346831946
Current ratio: 1.7749912922326716
Quick ratio: 1.395332636711947
Effective tax rate (%): 20.544554455445542
Interest coverage ratio: 8.253869969040247
COGS to revenue (%): 49.20535101760805
SG&A to revenue (%): 29.396295449348276
Free cash flow (dilution-adjusted): 2653000000
Buyback yield (%): 1.2958840532431666
Retained earnings: 40830000000
Inventory turnover: 3.9481651376146787
Receivables turnover: 5.976084728390844
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.923955952628298
FCF margin (%): 15.166933455293849
Revenue growth (%): 15.344543356412792
Rule of 40 score: 30.511476811706643
Financial ratios for EMR.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 83.05208333333334
Shares outstanding: 560100000
Market cap (USD): 46517471875.00001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for EMR.DE — quarterly report dated 2025-03-31
Total revenue: 4432000000
Gross profit: 2371000000
Operating income: 859000000
Net income: 485000000
Capital expenditures: 87000000
Operating cash flow: 241000000
Depreciation & amortization: 384000000
Net tangible assets: -8573000000
Owner earnings: 782000000
Return on net tangible assets (%): -9.121661028811385
Capex to operating income (%): 10.128055878928988
Buffett classification: The Great
Stock price: 86.66304347826087
P/E ratio: 25.020603428955624
Shares outstanding: 560100000
Book value: 19266000000
P/B ratio: 2.519462818030412
Market cap (USD): 48539970652.17391
Debt to equity: 0.7708398214471089
Current ratio: 0.7954084455098653
Quick ratio: 0.5910934906878111
Effective tax rate (%): 31.63751987281399
Interest coverage ratio: 9.988372093023257
COGS to revenue (%): 46.50270758122744
SG&A to revenue (%): 28.9485559566787
Free cash flow (dilution-adjusted): 95000000
Buyback yield (%): 0.45941519330113706
Retained earnings: 39977000000
Inventory turnover: 0.9300541516245487
Receivables turnover: 1.5277490520510169
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7592188102274187
FCF margin (%): 2.1435018050541514
Rule of 40 score: 2.1435018050541514
Financial ratios for EMR.DE — quarterly report dated 2025-06-30
Total revenue: 4553000000
Gross profit: 2393000000
Operating income: 908000000
Net income: 586000000
Capital expenditures: 93000000
Operating cash flow: 1070000000
Depreciation & amortization: 372000000
Net tangible assets: -7957000000
Owner earnings: 865000000
Return on net tangible assets (%): -10.870931255498304
Capex to operating income (%): 10.242290748898679
Buffett classification: The Great
Stock price: 93.80000000000001
P/E ratio: 49.054509803921576
Shares outstanding: 560100000
Book value: 19886000000
P/B ratio: 2.6419279895403807
Market cap (USD): 52537380000.00001
Debt to equity: 0.7477119581615207
Current ratio: 0.8453224002981737
Quick ratio: 0.6321282146850541
Effective tax rate (%): 20.98092643051771
Interest coverage ratio: 9.557894736842105
COGS to revenue (%): 47.441247529101695
SG&A to revenue (%): 27.805842301779048
Free cash flow (dilution-adjusted): 906000000
Buyback yield (%): 0.04758516698015774
Retained earnings: 40265000000
Inventory turnover: 0.9440559440559441
Receivables turnover: 1.5656808803301239
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8566934088406484
FCF margin (%): 19.898967713595432
Revenue growth (%): 2.7301444043321297
Rule of 40 score: 22.629112117927562
Financial ratios for EMR.DE — annual report dated 2025-09-30
Total revenue: 18016000000
Gross profit: 9519000000
Operating income: 3532000000
Net income: 2293000000
Capital expenditures: 431000000
Operating cash flow: 3098000000
Depreciation & amortization: 1518000000
Net tangible assets: -7369000000
Owner earnings: 3380000000
Return on net tangible assets (%): -45.86782467091871
Capex to operating income (%): 12.202718006795017
Buffett classification: The Great
Stock price: 93.80000000000001
P/E ratio: 22.912071522023552
Shares outstanding: 560100000
Book value: 20298000000
P/B ratio: 2.58830328111144
Market cap (USD): 52537380000.00001
Debt to equity: 0.6778500344861562
Current ratio: 0.8760845156680617
Quick ratio: 0.6501990405226089
Effective tax rate (%): 23.721881390593047
Interest coverage ratio: 9.126614987080103
COGS to revenue (%): 47.163632326820604
SG&A to revenue (%): 28.324822380106575
Free cash flow (dilution-adjusted): 2404000000
Buyback yield (%): 2.2212755946337635
Retained earnings: 40603000000
Inventory turnover: 3.839584274740172
Receivables turnover: 5.80973879393744
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.980197096403147
FCF margin (%): 13.343694493783303
Revenue growth (%): 2.995655156643037
Rule of 40 score: 16.33934965042634
Financial ratios for EMR.DE — quarterly report dated 2025-09-30
Total revenue: 4855000000
Gross profit: 2519000000
Operating income: 982000000
Net income: 637000000
Capital expenditures: 168000000
Operating cash flow: 1010000000
Depreciation & amortization: 379000000
Net tangible assets: -7369000000
Owner earnings: 848000000
Return on net tangible assets (%): -11.5076672547157
Capex to operating income (%): 17.10794297352342
Buffett classification: The Great
Stock price: 93.80000000000001
P/E ratio: 30.75959016393443
Shares outstanding: 560100000
Book value: 20298000000
P/B ratio: 2.58830328111144
Market cap (USD): 52537380000.00001
Debt to equity: 0.6778500344861562
Current ratio: 0.8760845156680617
Quick ratio: 0.6501990405226089
Effective tax rate (%): 20.100502512562816
Interest coverage ratio: 4.0578512396694215
COGS to revenue (%): 48.11534500514933
SG&A to revenue (%): 27.394438722966015
Free cash flow (dilution-adjusted): 777000000
Buyback yield (%): 0.038068133584126196
Retained earnings: 40603000000
Inventory turnover: 1.0555806597379123
Receivables turnover: 1.565623992260561
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.05281810551186
FCF margin (%): 16.004119464469618
Revenue growth (%): 6.632989237865145
Rule of 40 score: 22.637108702334764
Financial ratios for EMR.DE — quarterly report dated 2025-12-31
Total revenue: 4346000000
Gross profit: 2311000000
Operating income: 864000000
Net income: 606000000
Capital expenditures: 97000000
Operating cash flow: 699000000
Depreciation & amortization: 359000000
Net tangible assets: -7110000000
Owner earnings: 868000000
Return on net tangible assets (%): -12.20815752461322
Capex to operating income (%): 11.226851851851851
Buffett classification: The Great
Stock price: 135.12941176470588
P/E ratio: 32.707858050739745
Shares outstanding: 560100000
Book value: 20292000000
P/B ratio: 3.7298434619264618
Market cap (USD): 75685983529.41176
Debt to equity: 0.6859846244825547
Current ratio: 0.8405893536121672
Quick ratio: 0.6169201520912547
Effective tax rate (%): 21.806451612903228
Interest coverage ratio: 7.448275862068965
COGS to revenue (%): 46.824666359871145
SG&A to revenue (%): 28.578002761159688
Free cash flow (dilution-adjusted): 547000000
Buyback yield (%): 0.3303121507337609
Retained earnings: 40871000000
Inventory turnover: 0.8648533786655334
Receivables turnover: 1.4623149394347241
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.749928387281581
FCF margin (%): 12.586286240220893
Revenue growth (%): -10.484037075180225
Rule of 40 score: 2.102249165040668
Financial ratios for ENLT — annual report dated 2023-12-31
Total revenue: 72138674.03314917
Gross profit: 57554696.13259669
Operating income: 28963812.154696133
Net income: 27083149.171270717
Capital expenditures: 201927071.82320443
Operating cash flow: 52927900.55248619
Depreciation & amortization: 18175690.607734807
Net tangible assets: 243314364.64088398
Owner earnings: -156668232.0441989
Return on net tangible assets (%): -64.38922431703978
Capex to operating income (%): 697.1702162157006
Buffett classification: The Gruesome
Stock price: 19.14
P/E ratio: 98.80373792936018
Shares outstanding: 139807543
Book value: 396673204.41988957
P/B ratio: 6.745896479025764
Market cap (USD): 2675916373.02
Debt to equity: 1.8799713361890358
Current ratio: 1.1394721683136404
Quick ratio: 1.1394721683136404
Effective tax rate (%): 22.478235773193433
Interest coverage ratio: 1.7231580850329515
COGS to revenue (%): 20.216587144159114
R&D to revenue (%): 2.43047843701894
SG&A to revenue (%): 12.007260417703778
Free cash flow (dilution-adjusted): -150372099.4475138
Buyback yield (%): 0
Retained earnings: 17599447.513812155
Receivables turnover: 3.2877412531946772
Capitalized R&D asset: 2816749.576217981
ROCI (R&D-adjusted, %): 2.6389976442195833
Rosenberg metric: 16.668432143680032
FCF margin (%): -208.44866011595224
Revenue growth (%): 32.13586401592588
Rule of 40 score: -176.31279610002636
Financial ratios for ENLT — quarterly report dated 2024-09-30
Capital expenditures: 58694054.05405405
Depreciation & amortization: 7321891.891891891
Buffett classification: The Gruesome
Stock price: 16.9
Shares outstanding: 139807543
Market cap (USD): 2362747476.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENLT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.25
Shares outstanding: 139807543
Market cap (USD): 2411680116.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ENLT — annual report dated 2024-12-31
Total revenue: 109258904.10958904
Gross profit: 87150410.95890412
Operating income: 43496438.35616438
Net income: 18220547.94520548
Capital expenditures: 246371780.8219178
Operating cash flow: 69939452.05479452
Depreciation & amortization: 29832602.73972603
Net tangible assets: 243584657.5342466
Owner earnings: -198318630.1369863
Return on net tangible assets (%): -81.41671653072149
Capex to operating income (%): 566.4182864917298
Buffett classification: The Gruesome
Stock price: 17.25
P/E ratio: 132.3604605087963
Shares outstanding: 139807543
Book value: 394776438.35616446
P/B ratio: 6.108976834565288
Market cap (USD): 2411680116.75
Debt to equity: 2.1639950198968165
Current ratio: 1.195772245118573
Quick ratio: 1.195772245118573
Effective tax rate (%): 21.55579146025006
Interest coverage ratio: 1.6258435826275741
COGS to revenue (%): 20.23495781040384
R&D to revenue (%): 2.9090134028761647
SG&A to revenue (%): 9.741095048834616
Free cash flow (dilution-adjusted): -178722739.7260274
Buyback yield (%): 0
Retained earnings: 29566849.315068495
Receivables turnover: 5.695688190010997
Capitalized R&D asset: 4876858.4088587
ROCI (R&D-adjusted, %): 3.266504447392018
Rosenberg metric: 16.87986256045894
FCF margin (%): -163.5772765455936
Revenue growth (%): 51.45676791811058
Rule of 40 score: -112.12050862748302
Financial ratios for ENLT — quarterly report dated 2025-03-31
Total revenue: 29744715.447154474
Gross profit: 22525745.257452574
Operating income: 14913821.138211383
Net income: 27588888.888888888
Capital expenditures: 0
Operating cash flow: 17181300.81300813
Depreciation & amortization: 9156910.56910569
Net tangible assets: 275383739.83739835
Owner earnings: 36745799.45799458
Return on net tangible assets (%): 13.343489154331085
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.16
P/E ratio: 20.472824258880387
Shares outstanding: 139807543
Book value: 431227371.27371264
P/B ratio: 5.239208003440863
Market cap (USD): 2259289894.88
Debt to equity: 2.0966875289477507
Current ratio: 1.3115073793556207
Quick ratio: 1.3115073793556207
Effective tax rate (%): 19.494045265472028
Interest coverage ratio: 1.8220706552329238
COGS to revenue (%): 24.26975710198801
R&D to revenue (%): 2.336048397383334
SG&A to revenue (%): 10.792835146413017
Free cash flow (dilution-adjusted): 16717886.178861788
Buyback yield (%): 0
Retained earnings: 54844715.44715447
Receivables turnover: 0.7590456431535271
Capitalized R&D asset: 694850.9485094851
ROCI (R&D-adjusted, %): 1.0565250588920365
FCF margin (%): 56.204559120975226
Rule of 40 score: 56.204559120975226
Financial ratios for ENLT — quarterly report dated 2025-06-30
Total revenue: 34252802.359882005
Gross profit: 25448672.56637168
Operating income: 15784365.781710913
Net income: 1642772.8613569322
Capital expenditures: 118631268.43657817
Operating cash flow: 14022418.879056046
Depreciation & amortization: 10981710.914454278
Net tangible assets: 306302949.85250735
Owner earnings: -106006784.66076696
Return on net tangible assets (%): -34.60847657909005
Capex to operating income (%): 751.5745014857314
Buffett classification: The Gruesome
Stock price: 22.73
P/E ratio: 108.71176190875553
Shares outstanding: 139807543
Book value: 486266371.68141603
P/B ratio: 6.535153647170147
Market cap (USD): 3177825452.39
Debt to equity: 2.4329297403671215
Current ratio: 0.6981774922300932
Quick ratio: 0.6981774922300932
Effective tax rate (%): 14.638258736971183
Interest coverage ratio: 1.0273793752280014
COGS to revenue (%): 25.703385378540606
R&D to revenue (%): 2.5017869907076484
SG&A to revenue (%): 9.895191918496
Free cash flow (dilution-adjusted): -104987610.61946902
Buyback yield (%): 0
Retained earnings: 60098525.07374631
Receivables turnover: 0.803172099908005
Capitalized R&D asset: 1322482.2888936854
ROCI (R&D-adjusted, %): 0.941036688778445
Rosenberg metric: 4.20655295238358
FCF margin (%): -306.508090977204
Revenue growth (%): 15.155925497881329
Rule of 40 score: -291.35216547932265
Financial ratios for ENLT — quarterly report dated 2025-09-30
Total revenue: 41853776.43504532
Gross profit: 29964048.33836858
Operating income: 20551057.401812688
Net income: 9745317.220543807
Capital expenditures: 152763444.10876134
Operating cash flow: 21543504.531722054
Depreciation & amortization: 11825377.643504532
Net tangible assets: 408008459.2145015
Owner earnings: -131192749.24471301
Return on net tangible assets (%): -32.1544189297657
Capex to operating income (%): 743.3361754674822
Buffett classification: The Gruesome
Stock price: 31.16
P/E ratio: 111.7686171405127
Shares outstanding: 139807543
Book value: 591619033.2326283
P/B ratio: 7.363527532365637
Market cap (USD): 4356403039.88
Debt to equity: 2.308131355454003
Current ratio: 0.8838497738969892
Quick ratio: 0.8838497738969892
Effective tax rate (%): 22.70810370441367
Interest coverage ratio: 1.255727234128962
COGS to revenue (%): 28.407778483571057
R&D to revenue (%): 2.0962060403072127
SG&A to revenue (%): 11.283709649477393
Free cash flow (dilution-adjusted): -131840181.26888217
Buyback yield (%): 0
Retained earnings: 68205438.06646526
Receivables turnover: 0.8682430950306783
Capitalized R&D asset: 1680786.745509088
ROCI (R&D-adjusted, %): 1.0519687572641583
Rosenberg metric: 5.269233689180548
FCF margin (%): -315.0018767684934
Revenue growth (%): 22.190809368829395
Rule of 40 score: -292.811067399664
Financial ratios for ENLT — quarterly report dated 2025-12-31
Total revenue: 68507232.7044025
Gross profit: 56387106.91823899
Operating income: 16116666.666666666
Net income: 6626729.559748427
Capital expenditures: 204056918.2389937
Operating cash flow: 37795597.48427673
Depreciation & amortization: 12504088.050314466
Net tangible assets: 435273584.90566033
Owner earnings: -184926100.6289308
Return on net tangible assets (%): -42.48502712817068
Capex to operating income (%): 1266.1235878324326
Buffett classification: The Gruesome
Stock price: 45.46
P/E ratio: 139.36697495827568
Shares outstanding: 139807543
Book value: 627338993.7106919
P/B ratio: 10.131126820583095
Market cap (USD): 6355650904.78
Debt to equity: 2.567032158392892
Current ratio: 0.6726280609254207
Quick ratio: 0.6726280609254207
Effective tax rate (%): 29.439142809308557
COGS to revenue (%): 17.69174626927332
R&D to revenue (%): 1.7520988923723797
SG&A to revenue (%): 8.715509999862293
Free cash flow (dilution-adjusted): -167966666.66666666
Buyback yield (%): 0
Retained earnings: 75478930.81761006
Receivables turnover: 1.7655644703784747
Capitalized R&D asset: 2070920.807146099
ROCI (R&D-adjusted, %): 0.7414762641881418
Rosenberg metric: 30.117191425403256
FCF margin (%): -245.18092475201166
Revenue growth (%): 63.682321022385736
Rule of 40 score: -181.49860372962593
Financial ratios for ENLT — annual report dated 2025-12-31
Total revenue: 183101886.7924528
Gross profit: 140843710.6918239
Operating income: 71640251.57232705
Net income: 50535220.12578616
Capital expenditures: 569990566.0377358
Operating cash flow: 88883018.86792453
Depreciation & amortization: 47145283.018867925
Net tangible assets: 435273584.90566033
Owner earnings: -472310062.8930817
Return on net tangible assets (%): -108.50878143580628
Capex to operating income (%): 795.6289286090528
Buffett classification: The Gruesome
Stock price: 45.46
P/E ratio: 125.7667600726836
Shares outstanding: 139807543
Book value: 627338993.7106919
P/B ratio: 10.131126820583095
Market cap (USD): 6355650904.78
Debt to equity: 2.567032158392892
Current ratio: 0.6726280609254207
Quick ratio: 0.6726280609254207
Effective tax rate (%): 21.44669244343206
Interest coverage ratio: 1.8124075164282647
COGS to revenue (%): 23.079050052896967
R&D to revenue (%): 2.093552065729635
SG&A to revenue (%): 9.953388840800736
Free cash flow (dilution-adjusted): -484400000
Buyback yield (%): 0
Retained earnings: 75478930.81761006
Receivables turnover: 4.71889132020423
Capitalized R&D asset: 6541425.886122253
ROCI (R&D-adjusted, %): 3.2858383095995696
Rosenberg metric: 16.893418155775983
FCF margin (%): -264.5521619059396
Revenue growth (%): 67.58532248209049
Rule of 40 score: -196.96683942384914
Financial ratios for FR.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.897727272727273
Shares outstanding: 241514686
Market cap (USD): 6254681470.386364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FR.PA — annual report dated 2022-12-31
Total revenue: 21315957446.808514
Gross profit: 3667021276.595745
Operating income: 675531914.893617
Net income: 313829787.2340426
Capital expenditures: 826595744.6808511
Operating cash flow: 2029787234.0425534
Depreciation & amortization: 1895744680.851064
Net tangible assets: -2335106382.9787235
Owner earnings: 1382978723.4042554
Return on net tangible assets (%): -59.2255125284738
Capex to operating income (%): 122.36220472440947
Buffett classification: The Gruesome
Stock price: 15.510638297872342
P/E ratio: 11.936556345355932
Shares outstanding: 241514686
Book value: 4906382978.723404
P/B ratio: 0.7635047965915006
Market cap (USD): 3746046938.170213
Debt to equity: 1.5919340849956638
Current ratio: 0.8887226482139519
Quick ratio: 0.6658874135028989
Effective tax rate (%): 42.04322200392927
Interest coverage ratio: 3.1280788177339898
COGS to revenue (%): 82.79682587213655
R&D to revenue (%): 9.382642112092627
SG&A to revenue (%): 4.651394919399111
Free cash flow (dilution-adjusted): 423404255.31914896
Buyback yield (%): 1.419936542164203
Retained earnings: 1946808510.638298
Inventory turnover: 6.961812840956778
Receivables turnover: 7.845340642129994
Capitalized R&D asset: 2000000000
ROCI (R&D-adjusted, %): 14.289317694539033
FCF margin (%): 1.986325298198333
Rule of 40 score: 1.986325298198333
Financial ratios for FR.PA — annual report dated 2023-12-31
Total revenue: 24493333333.333332
Gross profit: 4390000000
Operating income: 931111111.111111
Net income: 333333333.3333333
Capital expenditures: 1026666666.6666666
Operating cash flow: 2735555555.5555553
Depreciation & amortization: 2038888888.8888888
Net tangible assets: -2882222222.2222223
Owner earnings: 1345555555.5555558
Return on net tangible assets (%): -46.684656900539714
Capex to operating income (%): 110.26252983293557
Buffett classification: The Gruesome
Stock price: 13.766666666666667
P/E ratio: 9.974556531800001
Shares outstanding: 241514686
Book value: 4844444444.444443
P/B ratio: 0.6863226971422021
Market cap (USD): 3324852177.266667
Debt to equity: 1.6217889908256886
Current ratio: 0.8639380530973452
Quick ratio: 0.6459255162241888
Effective tax rate (%): 33.92070484581498
Interest coverage ratio: 2.264864864864865
COGS to revenue (%): 82.07675557974959
R&D to revenue (%): 9.20431863545636
SG&A to revenue (%): 4.917437851569588
Free cash flow (dilution-adjusted): 484444444.4444444
Buyback yield (%): 0.06683672246893974
Retained earnings: 2116666666.6666665
Inventory turnover: 7.65031712473573
Receivables turnover: 8.856568903173965
Capitalized R&D asset: 3594444444.444444
ROCI (R&D-adjusted, %): 11.247024440830565
Rosenberg metric: 0.3614893617021275
FCF margin (%): 1.977862456904373
Revenue growth (%): 14.906090399427704
Rule of 40 score: 16.883952856332076
Financial ratios for FR.PA — annual report dated 2024-12-31
Total revenue: 22387500000
Gross profit: 4251041666.666667
Operating income: 957291666.6666667
Net income: 243750000
Capital expenditures: 1185416666.6666667
Operating cash flow: 2798958333.3333335
Depreciation & amortization: 2071875000
Net tangible assets: -2797916666.666667
Owner earnings: 1130208333.3333333
Return on net tangible assets (%): -40.394638868205504
Capex to operating income (%): 123.83025027203483
Buffett classification: The Gruesome
Stock price: 8.9375
P/E ratio: 8.855538486666667
Shares outstanding: 241514686
Book value: 4703125000
P/B ratio: 0.45895814083720926
Market cap (USD): 2158537506.125
Debt to equity: 1.5585825027685494
Current ratio: 0.8077728224265041
Quick ratio: 0.6157276781651042
Effective tax rate (%): 29.72972972972973
Interest coverage ratio: 2.3324873096446703
COGS to revenue (%): 81.01153917736833
R&D to revenue (%): 9.896705750977109
SG&A to revenue (%): 4.815745393634841
Free cash flow (dilution-adjusted): 459375000
Buyback yield (%): 1.2064495795311239
Retained earnings: 1998958333.3333335
Inventory turnover: 8.251658767772511
Receivables turnover: 8.925249169435215
Capitalized R&D asset: 4386102777.777778
ROCI (R&D-adjusted, %): 6.55557152350879
Rosenberg metric: -0.061637506160670145
FCF margin (%): 2.051926298157454
Revenue growth (%): -8.597577572128467
Rule of 40 score: -6.545651273971012
Financial ratios for FR.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -2797916666.666667
Buffett classification: The Gruesome
Stock price: 8.9375
Shares outstanding: 241514686
Book value: 4703125000
P/B ratio: 0.45895814083720926
Market cap (USD): 2158537506.125
Debt to equity: 1.5585825027685494
Current ratio: 0.8077728224265041
Quick ratio: 0.6157276781651042
Buyback yield (%): 0
Retained earnings: 1998958333.3333335
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FR.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -3644705882.352941
Buffett classification: The Gruesome
Stock price: 10.564705882352943
Shares outstanding: 241514686
Book value: 4641176470.588238
P/B ratio: 0.5497596654702153
Market cap (USD): 2551531623.858824
Debt to equity: 1.669961977186311
Current ratio: 0.7927980535279805
Quick ratio: 0.6138199513381996
Buyback yield (%): 0
Retained earnings: 2283529411.764706
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRED.V — annual report dated 2021-09-30
Capital expenditures: 1810.9375
Buffett classification: The Gruesome
Stock price: 0.78125
Shares outstanding: 64851051
Market cap (USD): 50664883.59375
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRED.V — annual report dated 2022-09-30
Total revenue: 0
Gross profit: -689.0510948905109
Operating income: -3780255.4744525542
Net income: -2443218.2481751824
Capital expenditures: 2960.5839416058393
Operating cash flow: -2697646.715328467
Depreciation & amortization: 689.0510948905109
Net tangible assets: 1698603.6496350365
Owner earnings: -2445489.7810218977
Return on net tangible assets (%): -143.97059499709292
Buffett classification: The Gruesome
Stock price: 0.45985401459854014
Shares outstanding: 64851051
Book value: 1698603.6496350362
P/B ratio: 17.55678327883745
Market cap (USD): 29822016.153284673
Debt to equity: 0
Current ratio: 6.113331424544094
Quick ratio: 6.113331424544094
Interest coverage ratio: -410.2138613861386
Free cash flow (dilution-adjusted): -2711752.5547445253
Buyback yield (%): 0
Retained earnings: -8948867.883211678
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -222.5507684070256
Rule of 40 score: 0
Financial ratios for FRED.V — annual report dated 2023-09-30
Total revenue: 0
Gross profit: -548.1481481481482
Operating income: -2878331.8518518517
Net income: -1983582.222222222
Capital expenditures: 521.4814814814814
Operating cash flow: -1673662.962962963
Depreciation & amortization: 548.1481481481482
Net tangible assets: -109120
Owner earnings: -1983555.5555555555
Buffett classification: The Gruesome
Stock price: 0.28148148148148144
Shares outstanding: 64851051
Book value: -109120
Market cap (USD): 18254369.91111111
Debt to equity: 0
Current ratio: 0.7328652098158994
Quick ratio: 0.7328652098158994
Interest coverage ratio: -1375.4860176991149
Free cash flow (dilution-adjusted): -1820359.9999999998
Buyback yield (%): 0
Retained earnings: -11065025.925925925
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRED.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.18518518518518517
Shares outstanding: 64851051
Market cap (USD): 12009453.888888888
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRED.V — annual report dated 2024-09-30
Total revenue: 0
Gross profit: -320
Operating income: -958779.2592592592
Net income: -833634.074074074
Capital expenditures: 0
Operating cash flow: -549697.7777777778
Depreciation & amortization: 320
Net tangible assets: 71991.85185185185
Owner earnings: -833314.074074074
Return on net tangible assets (%): -1157.5116525532724
Buffett classification: The Gruesome
Stock price: 0.18518518518518517
Shares outstanding: 64851051
Book value: 71991.85185185191
P/B ratio: 166.8168491290165
Market cap (USD): 12009453.888888888
Debt to equity: 0
Current ratio: 1.083878490010741
Quick ratio: 1.083878490010741
Interest coverage ratio: -929.8505747126436
Free cash flow (dilution-adjusted): -549697.7777777778
Buyback yield (%): 0
Retained earnings: -11898660
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1331.7885768965612
Rule of 40 score: 0
Financial ratios for FRED.V — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -37.76223776223777
Operating income: -343457.34265734267
Net income: -329267.8321678322
Capital expenditures: 0
Operating cash flow: -176374.1258741259
Depreciation & amortization: 37.76223776223777
Net tangible assets: -139171.32867132867
Owner earnings: -329230.06993006996
Buffett classification: The Gruesome
Stock price: 0.16783216783216784
Shares outstanding: 64851051
Book value: -139171.3286713286
Market cap (USD): 10884092.475524476
Debt to equity: 0
Current ratio: 0.8189575117500103
Quick ratio: 0.8189575117500103
Interest coverage ratio: -700.6333808844507
Free cash flow (dilution-adjusted): -311297.20279720286
Buyback yield (%): 0
Retained earnings: -11562268.531468531
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRED.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -33.56643356643357
Operating income: -182186.013986014
Net income: 185906.99300699303
Capital expenditures: 0
Operating cash flow: -94213.28671328671
Depreciation & amortization: 33.56643356643357
Net tangible assets: 39975.52447552448
Owner earnings: 185940.55944055947
Return on net tangible assets (%): 465.13600979620406
Buffett classification: The Gruesome
Stock price: 0.13286713286713286
P/E ratio: 11.587209645021384
Shares outstanding: 64851051
Book value: 39975.524475524435
P/B ratio: 215.54622041458956
Market cap (USD): 8616573.20979021
Debt to equity: 0
Current ratio: 1.068375856087157
Quick ratio: 1.068375856087157
Interest coverage ratio: -586.7702702702703
Free cash flow (dilution-adjusted): -94213.28671328671
Buyback yield (%): 0
Retained earnings: -11376361.538461538
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -455.7438992390454
Rule of 40 score: 0
Financial ratios for FRED.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -30.65693430656934
Operating income: -229741.60583941604
Net income: -211616.78832116787
Capital expenditures: 0
Operating cash flow: -103081.0218978102
Depreciation & amortization: 30.65693430656934
Net tangible assets: -161046.71532846714
Owner earnings: -211586.1313868613
Buffett classification: The Gruesome
Stock price: 0.3576642335766423
Shares outstanding: 64851051
Book value: -161046.71532846714
Market cap (USD): 23194901.45255474
Debt to equity: 0
Current ratio: 0.7233765309552965
Quick ratio: 0.7233765309552965
Free cash flow (dilution-adjusted): -103081.0218978102
Buyback yield (%): 0
Retained earnings: -12086213.13868613
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRED.V — annual report dated 2025-09-30
Total revenue: 0
Gross profit: -112.23021582733814
Operating income: -1241421.582733813
Net income: -849027.3381294964
Capital expenditures: 0
Operating cash flow: -618153.237410072
Depreciation & amortization: 112.23021582733814
Net tangible assets: -437107.91366906476
Owner earnings: -848915.1079136691
Buffett classification: The Gruesome
Stock price: 0.302158273381295
Shares outstanding: 64851051
Book value: -437107.91366906476
Market cap (USD): 19595281.597122304
Debt to equity: 0
Current ratio: 0.3663827532974924
Quick ratio: 0.3663827532974924
Interest coverage ratio: -3602.455114822547
Free cash flow (dilution-adjusted): -973366.1870503598
Buyback yield (%): 0
Retained earnings: -12405279.856115108
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRED.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -8.633093525179858
Operating income: -474215.8273381295
Net income: -492969.06474820146
Capital expenditures: 0
Operating cash flow: -238181.29496402878
Depreciation & amortization: 8.633093525179858
Net tangible assets: -437107.91366906476
Owner earnings: -492960.4316546763
Buffett classification: The Gruesome
Stock price: 0.302158273381295
Shares outstanding: 64851051
Book value: -437107.91366906476
Market cap (USD): 19595281.597122304
Debt to equity: 0
Current ratio: 0.3663827532974924
Quick ratio: 0.3663827532974924
Free cash flow (dilution-adjusted): -454588.4892086331
Buyback yield (%): 0
Retained earnings: -12405279.856115108
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FRED.V — quarterly report dated 2025-12-31
Total revenue: 0
Gross profit: -1.4598540145985401
Operating income: -161878.8321167883
Net income: -163207.29927007298
Capital expenditures: 0
Operating cash flow: -90826.27737226276
Depreciation & amortization: 1.4598540145985401
Net tangible assets: -611346.7153284671
Owner earnings: -163205.83941605838
Buffett classification: The Gruesome
Stock price: 0.2992700729927007
Shares outstanding: 64851051
Book value: -611346.7153284671
Market cap (USD): 19407978.766423356
Debt to equity: 0
Current ratio: 0.21796396511818986
Quick ratio: 0.21796396511818986
Interest coverage ratio: -414.53084112149537
Free cash flow (dilution-adjusted): -90826.27737226276
Buyback yield (%): 0
Retained earnings: -12749586.131386861
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GLO — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.28
Shares outstanding: 42766222
Market cap (USD): 311338096.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GLO — annual report dated 2022-10-31
Total revenue: -202981165
Net income: -206955801
Capital expenditures: 0
Operating cash flow: 71097300
Net tangible assets: 270392174
Owner earnings: -206955801
Return on net tangible assets (%): -76.53912387271978
Buffett classification: The Gruesome
Stock price: 3.72
Shares outstanding: 42766222
Book value: 270392174
P/B ratio: 0.5883688994637841
Market cap (USD): 159090345.84
Debt to equity: 0.7573986849190392
Free cash flow (dilution-adjusted): 71097300
Buyback yield (%): 0
Retained earnings: -134967246
Receivables turnover: -11.770984567793128
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GLO — annual report dated 2023-10-31
Total revenue: -12943003
Net income: -15287337
Capital expenditures: 0
Operating cash flow: 147981228
Net tangible assets: 222688816
Owner earnings: -15287337
Return on net tangible assets (%): -6.8648876376440935
Buffett classification: The Gruesome
Stock price: 3.11
Shares outstanding: 42766222
Book value: 222688816
P/B ratio: 0.597259228411363
Market cap (USD): 133002950.42
Debt to equity: 0.23350970620814654
Free cash flow (dilution-adjusted): 147981228
Buyback yield (%): 2.4447217070991045
Retained earnings: -143523204
Receivables turnover: -1.6819356797173133
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GLO — annual report dated 2024-10-31
Total revenue: 63888631
Net income: 62064226
Capital expenditures: 0
Operating cash flow: 37498168
Net tangible assets: 259548407
Owner earnings: 62064226
Return on net tangible assets (%): 23.912389491182658
Buffett classification: The Gruesome
Stock price: 4.34
P/E ratio: 2.990537632419681
Shares outstanding: 42766222
Book value: 259548407
P/B ratio: 0.7151090065445864
Market cap (USD): 185605403.48
Debt to equity: 0.200347983642219
COGS to revenue (%): 0
SG&A to revenue (%): 1.9095791863187679
Free cash flow (dilution-adjusted): 37498168
Buyback yield (%): 0.2772343856117567
Retained earnings: -78571180
Receivables turnover: 15.112548438541538
Capitalized R&D asset: 0
FCF margin (%): 58.693021611309845
Rule of 40 score: 58.693021611309845
Financial ratios for GLO — quarterly report dated 2024-10-31
Capital expenditures: 0
Net tangible assets: 259548407
Buffett classification: The Gruesome
Stock price: 4.34
Shares outstanding: 42766222
Book value: 259548407
P/B ratio: 0.7151090065445864
Market cap (USD): 185605403.48
Debt to equity: 0.200347983642219
Buyback yield (%): 0
Retained earnings: -78571180
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GLO — quarterly report dated 2025-04-30
Capital expenditures: 0
Net tangible assets: 237571475
Buffett classification: The Gruesome
Stock price: 4.38
Shares outstanding: 42766222
Book value: 237571475
P/B ratio: 0.7884618823029995
Market cap (USD): 187316052.35999998
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -100548112
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GLOB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 314.09
Shares outstanding: 43179556
Market cap (USD): 13562266744.039999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0